BR0014235A - Uso de ribose para impedir de cãibra e dor muscular - Google Patents

Uso de ribose para impedir de cãibra e dor muscular

Info

Publication number
BR0014235A
BR0014235A BR0014235-2A BR0014235A BR0014235A BR 0014235 A BR0014235 A BR 0014235A BR 0014235 A BR0014235 A BR 0014235A BR 0014235 A BR0014235 A BR 0014235A
Authority
BR
Brazil
Prior art keywords
pain
ribose
exercise
prevent muscle
muscle cramp
Prior art date
Application number
BR0014235-2A
Other languages
English (en)
Inventor
Terri Butler
Cyr John St
Original Assignee
Bioenergy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioenergy Inc filed Critical Bioenergy Inc
Publication of BR0014235A publication Critical patent/BR0014235A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicinal Preparation (AREA)
  • Finger-Pressure Massage (AREA)

Abstract

"USO DE RIBOSE PARA IMPEDIR CãIBRA E DOR MUSCULAR". Ribose administrada antes de exercício reduz ou impede cãibra e dor muscular induzidas por exercício. A ribose tomada antes e imediatamente depois do exercício reduz mais ainda ou impede cãibra e dor muscular induzidas por exercício.
BR0014235-2A 1999-09-24 2000-09-22 Uso de ribose para impedir de cãibra e dor muscular BR0014235A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/405,464 US6159943A (en) 1999-09-24 1999-09-24 Use of ribose to prevent cramping and soreness in muscles
PCT/US2000/026140 WO2001020969A2 (en) 1999-09-24 2000-09-22 Use of ribose to prevent cramping and soreness in muscles

Publications (1)

Publication Number Publication Date
BR0014235A true BR0014235A (pt) 2002-12-31

Family

ID=23603807

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014235-2A BR0014235A (pt) 1999-09-24 2000-09-22 Uso de ribose para impedir de cãibra e dor muscular

Country Status (13)

Country Link
US (1) US6159943A (pt)
EP (1) EP1235581B1 (pt)
JP (3) JP4945710B2 (pt)
CN (1) CN1247201C (pt)
AT (1) ATE322273T1 (pt)
AU (1) AU783796B2 (pt)
BR (1) BR0014235A (pt)
CA (1) CA2383284C (pt)
DE (1) DE60027197T2 (pt)
ES (1) ES2257319T3 (pt)
GB (1) GB2352175B (pt)
MX (1) MXPA02003150A (pt)
WO (1) WO2001020969A2 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6511964B2 (en) 1999-09-24 2003-01-28 Bioenergy, Inc. Method for treating acute mountain sickness
US6159943A (en) * 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
US6703370B1 (en) * 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
CA2325033C (en) * 1999-10-27 2007-05-22 Bioenergy Inc. Use of ribose to treat fibromyalgia
EP1282424A1 (en) 2000-01-07 2003-02-12 Bioenergy Inc. compositions for enhancing the immune response
WO2001052831A1 (en) 2000-01-20 2001-07-26 Bioenergy Inc. Use of ribose supplementation for increasing muscle mass and decreasing body fat in humans
FR2822642B1 (fr) * 2001-03-30 2005-03-04 Roquette Freres Denree alimentaire a liberation d'energie prolongee
EP1247525A1 (en) * 2001-04-02 2002-10-09 Bioenergy Inc. Use of a monosaccharide in the manufacture of a medicament against acute mountain sickness
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20030212006A1 (en) * 2002-05-13 2003-11-13 Seifert John G. Method for reducing free radical formation in healthy individuals undergoing hypoxic exercise and medical conditions with increased oxygen free radicals
US20050048136A1 (en) * 2003-08-27 2005-03-03 Choudhry Muhammad S. Rehydrating beverage with Rhodiola crenulata and D-ribose that enhances blood oxygen and relieves post-exertional muscle cramping and soreness
US20070105787A1 (en) * 2004-01-14 2007-05-10 St Cyr John A Use of ribose in recovery from anaesthesia
US20100099630A1 (en) * 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
ES2393786T3 (es) * 2004-04-29 2012-12-28 Ribocor, Inc. Método para mejorar la eficacia ventilatoria
US7968138B2 (en) * 2004-07-23 2011-06-28 Arnold Nerenberg Food sweetener
WO2006065881A2 (en) * 2004-12-14 2006-06-22 Bioenergy, Inc. Use of ribose to alleviate rhabdomyolysis and the side effects of statin drugs
US20070172542A1 (en) * 2005-07-18 2007-07-26 Next Proteins, Inc. Stimulant-containing nutrition bar product and method of manufacture
US7566463B2 (en) * 2006-05-03 2009-07-28 C. B. Fleet Company Oral rehydration compositions
JP5396387B2 (ja) * 2007-01-23 2014-01-22 バイオエナジー インコーポレイティド 心臓不整脈を治療するためのｄ−リボースの用途
US20090061016A1 (en) * 2007-09-05 2009-03-05 Selzer Jonathan A Seawater Based Dietary Supplement Product for Energy and Electrolyte Replacement
CA2757442A1 (en) * 2008-04-02 2009-10-08 Bioenergy, Inc. Use of ribose in first response to acute myocardial infarction
CA2734769A1 (en) * 2008-08-20 2010-02-25 Bioenergy, Inc. Use of d-ribose for fatigued subjects
WO2012027277A2 (en) * 2010-08-21 2012-03-01 Hydropep, Llc Compositions for reducing the deleterious effects of stress and aging
EP3411041A1 (en) 2016-02-01 2018-12-12 RiboCor, Inc. Use of ribose for treatment of subjects having congestive heart failure
US20190313682A1 (en) * 2018-04-12 2019-10-17 Metabolic Recovery Systems, LLC Compositions and methods for supplementing the diet

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570122A5 (pt) * 1970-12-23 1975-12-15 Givaudan & Cie Sa
JPS5921376A (ja) * 1982-07-26 1984-02-03 Akiji Kotani 魚肉ねり製品発色剤、および魚肉ねり製品の発色方法
US4605644A (en) * 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
US4719201A (en) * 1985-02-07 1988-01-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia
US4824660A (en) * 1985-06-06 1989-04-25 Paul S. Angello Method of determining the viability of tissue in an organism
JPS6232860A (ja) * 1985-08-06 1987-02-12 Riichiro Yamazaki 健康食品
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US4828845A (en) * 1986-12-16 1989-05-09 Warner-Lambert Company Xylitol coated comestible and method of preparation
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4968719A (en) * 1989-04-03 1990-11-06 Sigma Tau, Industrie Farmaceutiche Riunite Spa Method for treating vascular disease
US5114723A (en) * 1990-02-27 1992-05-19 University Of Texas System Board Of Regents Beverage compositions for human consumption
CA2048003A1 (en) * 1990-08-21 1992-02-22 Serge Burner Tricyclic pyridone derivatives
GB9101244D0 (en) * 1991-01-19 1991-02-27 Wellcome Found Amide derivatives and their therapeutic use
IT1247125B (it) * 1991-03-01 1994-12-12 Depha Team Srl Composizioni dietetiche o farmaceutiche per il ripristino del contenuto cellulare degli adenin nucleotidi nel muscolo scheletrico e cardiaco.
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4228215A1 (de) * 1992-08-25 1994-03-03 Pliml Wolfgang Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen
US5536751A (en) * 1994-05-09 1996-07-16 The United States Of America As Represented By The Secretary Of The Army Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof
EP0729758A3 (en) * 1995-03-02 1997-10-29 Pfizer Pyrazolopyrimidines and pyrrolopyrimidines to treat neuronal disorders and other diseases
US5707971A (en) * 1995-06-07 1998-01-13 Life Resuscitation Technologies, Inc. Modulation of glycolytic ATP production
GB9715340D0 (en) * 1997-07-22 1997-09-24 Cerestar Holding Bv Beverages for enhanced physical performance
JP4295840B2 (ja) * 1997-12-09 2009-07-15 株式会社林原生物化学研究所 血行改善剤
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6159943A (en) * 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles

Also Published As

Publication number Publication date
DE60027197T2 (de) 2006-08-24
AU3884201A (en) 2001-04-24
ATE322273T1 (de) 2006-04-15
CN1247201C (zh) 2006-03-29
DE60027197D1 (de) 2006-05-18
JP2003516315A (ja) 2003-05-13
JP2015052018A (ja) 2015-03-19
EP1235581B1 (en) 2006-04-05
US6159943A (en) 2000-12-12
MXPA02003150A (es) 2003-08-20
AU783796B2 (en) 2005-12-08
WO2001020969A3 (en) 2002-07-11
CN1450904A (zh) 2003-10-22
GB2352175B (en) 2001-07-18
EP1235581A2 (en) 2002-09-04
CA2383284A1 (en) 2001-03-29
GB2352175A (en) 2001-01-24
JP2011093910A (ja) 2011-05-12
ES2257319T3 (es) 2006-08-01
GB0023103D0 (en) 2000-11-01
WO2001020969A2 (en) 2001-03-29
JP6096401B2 (ja) 2017-03-15
CA2383284C (en) 2011-03-15
JP4945710B2 (ja) 2012-06-06

Similar Documents

Publication Publication Date Title
BR0014235A (pt) Uso de ribose para impedir de cãibra e dor muscular
BR9912508A (pt) Métodos e composições transdérmicas para alìvio da dor
YU42198A (sh) Farmaceutska kompozicija olanzapina
YU54702A (sh) Terapija povrede mozga, kičme i nerva
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
ATE332918T1 (de) Neoglycoproteine
BR0309544A (pt) Preparação farmacêutica contendo oxicodona e naloxona
ATE293458T1 (de) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
BR0110968A (pt) Antagonistas dos receptores de il-8
ATE263496T1 (de) Zusammensetzung zur vorbeugung von muskulärer erschöpfung und zur anpassung von skelettmuskel an intensive körperliche anstrengung
BR9808302A (pt) O uso de levobupivacaìna na cirurgia pediátrica
GB2365864B (en) Substituted nitrated catechols,their use in treatment of some central and peripheral nervous system disorders and pharmeceutical compositions containing them
AU7255198A (en) Methods and compositions for the prevention and treatment of muscle cramps and improving muscular strength in athletes
FR2775682B1 (fr) Traitement d'effluents aqueux par injection d'anhydride carbonique
MXPA01007952A (es) Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas.
BR0005319A (pt) Tratamento combinado para depressão e ansiedade
HUP9903375A2 (hu) Olanzapint és fájdalomcsillapító hatóanyagot tartalmazó szinergista hatású gyógyszerkészítmények
EP1517912A4 (en) METHODS AND COMPOSITIONS FOR TREATING PAIN AND PAIN DISEASES USING GENES 577, 20739 OR 57145
ES1026542Y (es) Dispositivo para realizar masaje muscular.
宋学军 et al. DETECTION OF RELEASE OF ASPARTATE AND GLUTAMATE IN CAT SPINAL DORSAL HORN FOLLOWING NOXIOUS STIMULATION OF CUTANEOUS AND MUSCULAR AFFERENT FIBERS USING MICRODIALYSIS
ITCO970005A0 (it) Attrezzo motorizzato per l'esecuzione di esercizi ginnici stiramento muscolare globale di ginnastica correttiva-posturale e respiratoria
UA37388A (uk) Спосіб стимуляції розвитку репродуктивної функції тварин
魏波 PROFESSOR WEI FENGPO'S CLINICALEXPERIENCE IN APPLICATION OFFOUR" FENG" ACUPOINTS
高村博正 John Steinbeck and his dramatic world: a study of his dramatized life, works, and adapted works
IT1286435B1 (it) Attrezzo per l'esecuzione di esercizi ginnici di stiramento muscolare e di esercizi di respirazione

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]